Ann: Neurotech Completes $9.0M Placement, page-21

At the end of the day, the 20 week results just weren’t strong enough, at least for the short term. the market has voted on that so interpret the results how you want, but the market cap is now less than pre the result despite all the new cash and stock on issue.. this isn’t an I told you so, just a good lesson for all, don’t fall in love with a stock, I have always agreed long term there is potential here… but that’s all it is potential…. There is no guarantee that they will ever sell a drop or get approved… I think they have a good chance of being successful.. but they are 2-3 years from FDA approval, so that far from revenue ( unless they go down the snake skip oil path and sell next to the black ores and Swiss products in the pharmacy)…

the qn is will of get cheaper than this. I think so. So not re entering yet. I’ll probably just wait for the options to list in December and reassess…

Its been a bit tough for new buyers. Longer term there is some hope.

gltah.. DYOR.